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Abstract
Patient-specific analysis of molecular networks is a promising strategy for making individual risk predictions and treatment
decisions in cancer therapy. Although systems biology allows the gene network of a cell to be reconstructed from clinical
gene expression data, traditional methods, such as Bayesian networks, only provide an averaged network for all samples.
Therefore, these methods cannot reveal patient-specific differences in molecular networks during cancer progression. In this
study, we developed a novel statistical method called NetworkProfiler, which infers patient-specific gene regulatory
networks for a specific clinical characteristic, such as cancer progression, from gene expression data of cancer patients. We
applied NetworkProfiler to microarray gene expression data from 762 cancer cell lines and extracted the system changes
that were related to the epithelial-mesenchymal transition (EMT). Out of 1732 possible regulators of E-cadherin, a cell
adhesion molecule that modulates the EMT, NetworkProfiler, identified 25 candidate regulators, of which about half have
been experimentally verified in the literature. In addition, we used NetworkProfiler to predict EMT-dependent master
regulators that enhanced cell adhesion, migration, invasion, and metastasis. In order to further evaluate the performance of
NetworkProfiler, we selected Krueppel-like factor 5 (KLF5) from a list of the remaining candidate regulators of E-cadherin
and conducted in vitro validation experiments. As a result, we found that knockdown of KLF5 by siRNA significantly
decreased E-cadherin expression and induced morphological changes characteristic of EMT. In addition, in vitro experiments
of a novel candidate EMT-related microRNA, miR-100, confirmed the involvement of miR-100 in several EMT-related aspects,
which was consistent with the predictions obtained by NetworkProfiler.
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Introduction
Currently, several large-scale omics projects, such as the National
Cancer Institute’s Cancer Genome Atlas (http://cancergenome.nih.
gov/) and the Sanger Institute’s Cancer Genome Project (http://
www.sanger.ac.uk/genetics/CGP/), produce large amounts of data,
including genomic, epigenomic, and transcriptomic information,
about cancer patients or cell lines. Two challenges in omics are to
construct and analyze patient-specific molecular networks to develop
a comprehensive understanding of the molecular mechanisms of
tumorigenesis and to identify molecules that are critical for tumor
proliferation and progression [1]. If these challenges can be
overcome, it may be possible to personalize cancer therapy, improve
its efficacy, and reduce its toxicity and cost [2,3].
Systems biology integrates various types of omics data and
computational tools to represent and analyze complex biological
systems. For example, gene network estimation that is based on
Bayesian networks or mutual information networks can reconstruct
biological systems from gene expression data [4]. However, most
traditional gene network estimation methods construct a static
network by using gene expression data from different cellular
conditions. As a result, these methods only produce an averaged
network for all patients and cannot reveal patient-specific molecular
mechanismsofcancer.Inaddition,itisverydifficulttoinferapatient-
specific gene network from only a few gene expression profiles of the
patient without making any assumptions about the network.
In this study, we developed a novel statistical method called
NetworkProfiler, which infers patient-specific gene regulatory
networks from a dataset of cancer gene expression profiles.
NetworkProfiler is based on a statistical graphical model with varying
coefficients and a kernel-based data integration method with elastic
net regularization for parameter estimation. A key feature of
NetworkProfiler is that the strengths of the relationships between
genes are allowed tovary depending oncancer characteristics, suchas
cancer progression, metastasis, disease-free survival, and drug
sensitivity. NetworkProfiler groups samples according to the specific
cancer characteristics so that neighboring samples have common
gene regulatory systems. Then, by integrating the gene expression
profiles of neighboring samples with a kernel method, NetworkPro-
filer produces a gene regulatory network for each sample. Finally, we
analyzed 2 post-analysis to discover upstream regulatory genes and
downstream target genes for specific cancer characteristics. Network-
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20804Profiler is the first algorithm for constructing patient-specific gene
regulatory networks from clinical cancer gene expression data to
elucidate cancer heterogeneity.
We applied NetworkProfiler to gene expression microarray data
from 762 cancer cell lines to determine system changes related to the
epithelial-mesenchymal transition (EMT). The epithelial-mesenchy-
mal transition (EMT) is a process that changes proliferating cellsfrom
an aplanetic state to a motile state [5], which allows cancer cells to
leave the primary tumor and metastasize. The loss of E-cadherin, a
cell adhesion molecule, is a biomarker of EMT [5]. NetworkProfiler
identified 25 key regulators of E-cadherin, of which half have been
previously described and the other half were novel candidates.
NetworkProfiler also revealed regulatory changes in miR-141, ZEB1,
and E-cadherin. Specifically, our results suggested that decreased
expression of miR-141 in mesenchymal cells disrupts the negative
feedback loop between miR-141 and ZEB1,w h i c hw o u l da l l o wZEB1
to decrease the expression of E-cadherin during the EMT. In
addition, we predicted 45 EMT-dependent putative master regula-
tors that control sets of genes involved in cell adhesion, migration,
invasion and metastasis, namely, 17 of which are downstream targets
of TGFB1, a master switch of the EMT. To further validate the
performance of NetworkProfiler, we experimentally evaluated in silico
predictions obtained by NetworkProfiler. We consequently found
that knockdown of KLF5, a new candidate regulator of E-cadherin,
decreased E-cadherinexpressionandinduced morphological changes
characteristic of EMT. In addition, the functional involvement of
miR-100 was validated in some EMT-related aspects, which was
consistent with the predictions obtained by Network Profiler.
Results
Overview of NetworkProfiler
Here, we provide an overview of NetworkProfiler; please refer to
the Methods section for a complete description. NetworkProfiler is a
modulator-dependent graphical model because it includes a
modulator (M) variable in addition to regulator (R)a n dt a r g e t( T)
variables (genes). R controls the transcription of T and M is a
cofactor that modulates the interaction between R and T.I nt h i s
study, we defined M as a biological or a clinical feature that is related
to cancer, such as drug response, survival risk, or a molecule or
pathway that is related to cancer initiation, progression, or metastasis.
The relationships between R, T,a n dM are illustrated in Figure 1a.
Asshownin Figure 1b, the strengthof the relationshipbetweenR and
T varies depending on the value of M.T h u s ,M does not affect R
and T directly; instead, it influences the strength of the relationship
between R and T. In contrast, existing graphical models, such as
Bayesian networks and mutual information networks [4], do not
consider the effect of M (Figure 1c), so the strength of the relationship
between R and T remains constant for all values of M (Figure 1d).
In addition, NetworkProfiler can infer the relationships between
R and T, given a value of M. As a result, we could use
NetworkProfiler to construct patient-specific networks with varying
R-T relationships that reflect changes in the feature of interest in
cancer patients. A simple example with synthetic data for R, T,a n d
M is shown in Figure 2a. In this example, we assume that R
regulates T only with a high value of M (Figure 2b). In this case,
most existing methods that only consider R and T in all of the
samples (Figure 2c) and ignore M would conclude that R does not
regulate T. In contrast, NetworkProfiler attempts to quantify the
strength of the relationship between R and T for a specific value m
ofM byreweightingthedataaccordingtothevalueofM toidentify
the neighborhood of samples with values of M that are close to m.
Then, NetworkProfiler measures the dependency between R and T
on the basis of these neighboring samples. The optimization of the
size of the neighborhood is explained in the Method section.
A schematic representation of the entire analytical process of
NetworkProfiler is shown in Figure 3. NetworkProfiler used 2
inputs: (1) gene expression data and (2) the modulator for each
sample (Figure 3a). The gene expression data was represented as a
p|n matrix, where p is the number of genes and n is the number
Figure 1. The relationships between a regulator (R), a target(T), and a modulator (M) in NetworkProfiler and existing graphical
models. (a). The relationships between R, T and M in NetworkProfiler. The directed solid-line edge from R to T represents ‘‘R regulates the
transcript of T’’. The directed dot-line edge from M to the edge between R and T describes ‘‘M controls the strength of the relationship between R
and T’’. (b). The strength of the relationship between R and T in NetworkProfiler that varies depending on the value of M. (c). The relationships
between R and T in existing graphical models that do not consider the effect of M. (d). The strength of the relationship between R and T in existing
graphical models that remains constant for all values of M.
doi:10.1371/journal.pone.0020804.g001
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then we directly applied NetworkProfiler to these inputs. However,
if the modulator was a variable that is difficult to observe, then we
used a signature-based hidden modulator extraction algorithm to
estimate the value of the modulator. The output of NetworkPro-
filer is a set of gene networks for every value of M (i.e., sample-
specific gene networks) shown in Figure 3b.
Afterwards, we used 2 post-analysis techniques to extract
biological information from the networks. The first technique
identified upstream regulators of a target gene of interest in the
constructed modulator-dependent gene networks. To evaluate the
modulator-dependent strength of a regulator for the target gene,
we created a measure called the regulatory effect. The regulatory
effect profiles of the upstream regulators for specific target genes
are shown in Figure 3c. The second technique discovered putative
master regulators that control downstream target gene sets with
previously curated functions. To evaluate the enrichment of the
target genes on a functional gene set, we created measure called
the enrichment score. The resulting regulator-function matrix
(Figure 3d) illustrates the candidate regulators (rows) of functions
(columns) that are enhanced in the target genes.
Identification of system changes in the epithelial-
mesenchymal transition
To identify system changes during the EMT, we applied
NetworkProfiler to gene expression profiles of 762 cancer cell lines
from the Sanger Cell Line Project (http://www.broadinstitute.
org/cgi-bin/cancer/datasets.cgi). This dataset included the ex-
pression profiles of 22,777 probes, which correspond to 13,006
mRNAs in these cancer cell lines from the Affymetrix GeneChip
Figure 2. A regulatory change between a regulator (R) and a target (T) depending on the value of a modulator M. (a). A simple
example with synthetic data from 1000 samples for R, T, and M where x-, y-, and z-axises correspond to the expressions of R and T, and the values
of M, respectively. (b). The 3 scatter plots of R and T that are conditioned on the value of M. The left, middle, and right figures represent the scatter
plots from 1-st sample to 333-th sample, from 334-th sample to 666-th sample, and from 667-th sample to 1000-th sample in order of ascending M,
respectively. (c). The scatter plot of R and T that are not conditioned on the value of M.
doi:10.1371/journal.pone.0020804.g002
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profiles of 502 human microRNAs from bead-based oligonucle-
otide arrays. The MAS5-normalized mRNA dataset was further
transformed to the log scale and quantile-normalized. During the
mapping of the probes to genes, we selected 1 probe for each gene
that had the largest variance, which produced a final 13,508
(genes) | 762 (cancer cell lines) gene expression matrix.
In this study, we considered transcription factors, nuclear
receptors, and microRNAs to be potential regulators. To identify
transcription factors and nuclear receptors, we selected human
genes that were annotated as a ‘‘transcription regulator’’ or
‘‘ligand-dependent nuclear receptor’’ from the Ingenuity Knowl-
edge Base (IKB; http://www.ingenuity.com). We also included
some transcription factors that were not annotated in the IKB but
were annotated in the Biobase Knowledge Library (BKL; http://
biobase-international.com/). We mapped a total of 1230 genes in
the HG-U133A microarray gene set to 1183 transcription factors
and 47 nuclear receptors (Table S1). In addition, we included 502
human miRNA probes (Table S2).
To calculate the modulator values for the EMT in the 762 cancer
cell lines, we applied a signature-based hidden modulator extraction
algorithm (see Methods for details) to the expression data. First, we
selected 122 genes labeled ‘‘EMT_UP’’, ‘‘EMT_DN’’, ‘‘JECHLIN-
GER_EMT_UP’’, and ‘‘JECHLINGER_EMT_DN’’ from Molec-
ular Signatures Database v2.5 ([6]; http://www.broadinstitute.org/
gsea/msigdb/index.jsp). Then, this algorithm narrowed the set to
Figure 3. A schematic representation of the entire analytical process of NetworkProfiler. (a). Inputs of NetworkProfiler: gene expression
data matrix and the modulator for each sample. (b). Outputs of NetworkProfiler: a set of gene networks for every value of M (i.e., sample-specific
gene networks). (c). The regulatory effect profiles of the upstream regulators for a specific target gene. (d). The resulting regulator function matrix
whose columns are the candidate regulators and rows are functions that are enhanced in the target genes.
doi:10.1371/journal.pone.0020804.g003
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extraction of expression module (EEM) [7] (Table S3) and
computed the first principal component of these 50 genes as hidden
values of the EMT-related modulator (Table S4). Since the
direction of the first principal component did not always correspond
to that of the EMT, we changed the sign of the modulator values by
Figure 4. Expression profiles of the 50 functionally coherent genes in ascending order of the EMT-related modulator values. The
heatmap represents normalized expression profiles so that the mean and variance for each gene are 0 and 1, respectively. The red color represents
positive expressions and the green color represents negative expressions. The upper strings indicate cell line names which are known to be epithelial
or mesenchymal. The upper horizontal color bar represents the values of the EMT-related modulator with the signature-based hidden modulator
extraction algorithm. The bottom horizontal color bar shows primary histories of 762 cancer cell lines whose color corresponds to one of the eight
primary histories or the other histories (black). The bottom histograms represent frequencies of the primary histories between samples with the 200
lowest and 200 highest values of the EMT-related modulator, respectively.
doi:10.1371/journal.pone.0020804.g004
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lower modulator values than mesenchymal-like cells.
Figure 4 shows the expression profiles of the 50 functionally
coherent genes in ascending order of the EMT-related modulator
values. These modulator values clearly discriminated cell lines that
were epithelial-like or mesenchymal-like. Specifically, cells with
smaller or larger modulator values had more epithelial or
mesenchymal phenotypes, respectively. Furthermore, many carci-
nomas and squamous tumors had low modulator values, while
many gliomas and melanomas had high values. By using these
EMT-related modulator values, NetworkProfiler constructed 762
regulatory gene networks that are related to the EMT. The list of
the estimated edges in each of these networks can be downloaded
from the supporting web site (Files S1, S2, and S3; http://bonsai.
hgc.jp/*shima/NetworkProfiler).
Identification of regulators of E-cadherin that induce the
epithelial-mesenchymal transition
To identify possible regulators that might control the
expression of E-cadherin during the EMT, we calculated the
regulatory effects of the upstream regulators of E-cadherin. Out
of 1732 potential regulators, NetworkProfiler inferred that 370 of
them may control the expression of E-cadherin in any of the 762
cancer cell lines (Table S5). These putative regulators were
ranked according to the change in their regulatory effect during
the EMT. Although we did not include any information on
known E-cadherin regulators, about half of the 25 highest ranked
regulators were previously reported in the literature (Table 1).
For example, 2 zinc finger transcription factors, ZEB1 and ZEB2,
are direct repressors of E-cadherin and are involved in the EMT
[9,15]. In addition, the miR-200 family indirectly suppresses the
EMT by inhibiting the translation of ZEB1 and ZEB2 mRNAs
[8]. Similarly, miR-192 inhibits the translation of ZEB2 [13,14].
In addition, SNAI2, a member of the Snail superfamily of zinc
finger transcription factors, also is involved in the EMT [16].
Likewise, TCF4 (also known as E2-2), a class I bHLH
transcription factor, is an EMT regulator; its isoforms induce
the EMT in MDCK kidney epithelial cells [12]. In contrast,
FOXA1 and FOXA2 are positive regulators of E-cadherin, which
suppress the EMT in pancreatic ductal adenocarcinoma [11].
KLF4 also inhibits the EMT by regulating E-cadherin expression
[10]. NetworkProfiler also identified several other known direct
repressors of E-cadherin, such as TWIST1 [17] and TCF3 (also
known as E47) [18]; however, these regulators were ranked 38th
and 84th, respectively.
The other half of the 25 highest ranked regulators has not yet
been reported and may be novel EMT-dependent regulators of E-
cadherin. For example, although the relationship between
GRHL2 and EMT is not known, GRHL2 is required for
morphogenesis of epidermal and tracheal cells and plays an
important role in regulating the expression levels of E-cadherin in
Drosophila post-embryonic neuroblasts [19]. ZNF217 binds the E-
cadherin promoter [20], which suggests that ZNF217 might be a
transcription factor for E-cadherin.
Next, we compared the performance of NetworkProfiler with
that of a structural equation model (SEM) of E-cadherin that was
inferred by the elastic net [22]. This model was equivalent to a
regression model where the response variable is the expression of
E-cadherin and the explanatory variables are the 1732 regulator
expressions. The significance of each regulator was evaluated
based on the number of non-zero regression coefficients in 1000
bootstrapped datasets. The SEM inferred 627 putative regulators
(Table S6). Among these putative regulators, there were only 6
regulators, namely, ZEB1, miR-141, ZEB2, TCF3, miR-200b, and
miR-200c, in the 25 highest ranked regulators that were previously
reported in the literature. This result suggested that NetworkPro-
filer was superior to the traditional gene network estimation
methods to identify regulators of E-cadherin that are involved in
the EMT. Moreover, NetworkProfiler can reveal regulatory
changes among genes during the EMT. Figures 5a and 5b show
the regulatory profiles of putative regulators of E-cadherin when
the lengths of the paths from the regulators to E-cadherin is 1 and
2, respectively.
NetworkProfiler can also predict mechanistic interpretations
of published experiments. For example, it is known that ZEB1
and ZEB2 induce EMT by repressing E-cadherin transcription
and that ectopic expression of the miR-200 family (miR-200a,
miR-200b, miR-200c, and miR-141) or miR-205 leads to
downregulation of ZEB1 and ZEB2, upregulation of E-
cadherin, and mesenchymal-epithelial transition (MET) in cells
[8]. As the relationships between these genes, the prediction of
NetworkProfiler provides the following results. As shown in
Figures 6c and 6d, although the expression of miR-141 had a
strong positive effect on that of E-cadherin in epithelial-like
cells, this effect decreases during the EMT. In contrast, although
the expression of ZEB1 had a weak negative effect on that of E-
cadherin in epithelial-like cells, this effect increased during the
EMT. Interestingly, miR-141 and ZEB1 had a strong, direct
Table 1. 25 top-ranked regulators of E-cadherin for the
change in the regulatory effect change among the EMT with
published evidence.
regulator type regulatory effect change Evidence
IRF6 A 101.04
miR-141 A 87.58 [8]
GRHL2 A 64.13
ZEB1 (SIP1) I 50.72 [9]
LSR I 46.89
miR-200b A 31.55 [8]
KLF4 A 26.28 [10]
OVOL2 A 22.08
miR-200a A 17.70 [8]
FOXA2 A 17.26 [11]
TCF4 (E2.2) I 14.15 [12]
ELF3 A 13.58
ZNF217 A 13.53
MYB A 12.50
KLF5 A 12.42
miR-192 A 12.30 [13, 14]
FOXA1 A 11.69 [11]
ZNF165 A 11.39
NKX2-1 A 11.21
HNF1B A 11.08
TFE3 A 11.01
ZEB2 (dEF) I 10.66 [15]
TRIM29 I 9.87
SNAI2 I 9.74 [16]
The labels ‘‘A’’ and ‘‘I’’ indicate 2 types of the regulator: activator (A) and
inhibitor (I). See Table S5 for the complete table of the 370 putative regulators
for E-cadherin.
doi:10.1371/journal.pone.0020804.t001
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modulator values were low. This implied that there is a negative
feedback loop between miR-141 and ZEB1 in epithelial-like
cells, which is consistent with a previous study [23]. Further-
more, during the EMT, the expression levels of miR-141 and E-
cadherin decreased, while the expression level of ZEB1
Figure 5. Regulatory effect profiles of the putative regulators of E-cadherin among the EMT. (a). The regulatory effect profiles of the 13
putative regulators among the EMT when the length of the paths from the regulators to E-cadherin is 1 where rows indicate the putative regulators
of E-cadherin and columns indicate samples (cancer cell lines). The positive (red) and negative (green) regulatory effect indicate that the parent
regulator controls the transcript of E-cadherin positively and negatively, respectively. (b). The regulatory effect profiles of the 13 putative regulators
among the EMT when the length of the paths from the regulators to E-cadherin is 2.
doi:10.1371/journal.pone.0020804.g005
Figure 6. Regulatory changes among miR-141, ZEB1, and E-cadherin among the EMT. (a). The relationship among miR-141, ZEB1, and
E-cadherin in epithelial-like cells. (b). The relationship among miR-141, ZEB1, and E-cadherin in mesenchymal-like cells. (c). The expression profiles of
miR-141 (left), ZEB1 (middle), and E-cadherin (right) in order of ascending the EMT-related modulator values. The green and red colors indicate
epithelial- and mesenchymal-like cells, respectively. (d). The regulatory effects from ZEB1 to miR-141, from miR-141 to ZEB1, from miR-141 to
E-cadherin, and from ZEB1 to E-cadherin when the length of the paths is 1.
doi:10.1371/journal.pone.0020804.g006
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evidence.
regulator function -log10(q-value) mode of action (E[M) evidence
AX AY IX IY {
FOSL1 migration 9.82 29 2 42 3 41 [25]
invasion 8.42 14 2 24 3 22 [26]
EPAS1 adhesion 5.90 26 1 10 0 16 [27]
migration 7.66 32 1 14 0 24 [28]
KLF5 migration 5.93 28 2 27 5 25 [29]
AHR metastasis 3.67 12 0 11 0 9 [30]
FOXF1 metastasis 6.10 24 0 9 0 8 [31]
migration 6.09 29 0 17 0 14 [32]
ELK3 migration 6.23 41 8 17 7 19 [33]
SMAD3 adhesion 4.57 9 3 23 0 10 [34]
metastasis 3.12 5 1 12 1 9 [35]
migration 5.24 14 5 26 1 21 [36]
EMT 2.47 1 1 2 0 0 [37]
WWTR1 migration 5.08 32 0 17 3 16 [38]
invasion 3.48 17 0 8 2 5 [38]
hsa-miR-145 invasion 2.52 13 0 8 3 17 [39]
CEBPD metastasis 4.88 17 2 10 0 9 [31]
TGFB1I1 adhesion 5.12 25 2 23 5 11 [40]
HIF1A adhesion 3.84 10 0 25 3 10 [27]
metastasis 4.45 14 1 14 0 8 [41]
migration 5.00 18 3 25 4 21 [42]
invasion 3.65 12 0 9 3 10 [43]
SNAI2 migration 3.45 36 2 25 14 25 [25]
ELF3 adhesion 7.87 24 4 24 11 14 [44]
invasion 4.45 9 3 18 6 21 [44]
SOX9 adhesion 6.80 18 2 19 0 26 [45]
migration 5.46 28 2 15 1 23 [46]
GLI3 migration 4.53 24 7 24 7 26 [47]
TCF7L2 migration 4.52 19 10 18 1 27 [48]
NFKBIA adhesion 2.73 12 2 14 3 12 [49]
metastasis 2.39 5 0 5 3 9 [50]
migration 3.98 18 2 18 7 23 [51]
invasion 2.69 9 2 5 2 12 [50]
VAV1 adhesion 5.51 3 5 15 3 14 [52]
migration 5.10 7 10 16 5 16 [53]
JUN adhesion 3.03 15 4 6 5 6 [54]
migration 3.31 19 2 7 7 14 [25]
invasion 2.07 8 2 7 2 5 [55]
ETV1 invasion 2.50 13 1 13 5 7 [56]
PDLIM1 adhesion 4.27 16 6 17 6 29 [57]
MAFB metastasis 4.41 9 0 3 8 6 [31]
GATA6 metastasis 3.25 11 3 4 1 4 [31]
RUNX1 adhesion 6.27 15 5 16 12 14 [58]
migration 2.46 23 7 20 7 20 [59]
YAP1 migration 3.30 7 2 20 0 9 [60]
The labels ‘‘AX’’, ‘‘AY’’, ‘‘IX’’, and ‘‘IY’’, and ‘‘{’’ indicate the number of the five modulator modes of action for the relationship between a regulator and its target included
in the functional gene set: ‘‘the activation of a regulator on the expressions of its target genes with the functional category was increased by the modulator’’, ‘‘inhibition
increased’’, ‘‘activation decreased’’, ‘‘inhibition decreased’’, and ‘‘the modulator mode of action is not determined’’, respectively.
doi:10.1371/journal.pone.0020804.t002
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miR-141 disrupts the negative feedback loop between miR-141
a n dZ E B 1( F i g u r e s6 aa n d6 b ) ,w h i c hw o u l da l l o wZ E B 1t o
decrease the expression of E-cadherin, as illustrated in Figure 6c.
It should be noted that these results cannot be predicted by
traditional graphical models which infer a static gene network
structure.
Identification of relationships between regulators and
epithelial-mesenchymal transition-related functional
gene sets
The EMT-dependent relationships between downstream target
genes for each regulator and previously curated functional gene
sets in each sample were analyzed by applying gene set analysis
(see Methods for details) to the constructed gene networks for 762
cancer cell lines. We tested five curated gene sets included in
Ingenuity Knowledge Base (IKB; http://www.ingenuity.com).
These gene sets were related with adhesion, migration, invasion, and
metastasis which were hallmarks of EMT [5], and EMT itself. By
using gene set analysis, the statistical significances (q-values) for the
enrichments of downstream genes for the 1732 regulators on the
five functional gene sets were calculated in each of the 762 cell
lines. These results can be downloaded from the supporting web
site (File S4; http://bonsai.hgc.jp/*shima/NetworkProfiler).
To search for regulators that strongly affected the five EMT-
related functional gene sets, the change in the enrichment score
during the EMT and their integral q-value were calculated. The
result was summarized by a regulator function matrix (Table S7).
We focused on 45 regulators with the integral q-values less than
10{10 as putative master regulators that strongly enhanced the
Figure 7. Induction of EMT by KLF5 knockdown in A549 NSCLC
cell line. (a) Phase contrast images of A549 cells 72 hours after siRNA
transfection, showing a fibroblast-like morphology in siKLF5 treated
cells. TGF-b treatment serves as a positive control for EMT induction in
A549 cells. (b) Representative immunofluorescence staining images,
showing reduced E-cadherin expression in siKLF5-treated A549 cells. (c)
Western blot analysis of E-cadherin and vimentin, showing EMT-related
changes in their expression in A549 cells treated with two differenct
siRNAs.
doi:10.1371/journal.pone.0020804.g007
Figure 8. miR-100-induced changes in biologic characteristics
in A549 NSCLC cell line. (a) Quantitative real-time RT-PCR analysis of
miR-100 in six NSCLC cell lines, showing low miR-100 expression in
A549, NCI-H727 and NCI-H1437. (b) Motility assay showing increased
migration in miR-100-transfected A549 cells. Error bars indicate SE in
three independent experiments (*, pv0:05). NC#2, negative control. (c)
Western blot analysis of E-cadherin, vimentin and a-tubulin, showing
lack of noticeable changes in miR-100-transfected A549 cells (d)
Representative phase contrast microscopic images showing negligible
changes in miR-100-trasfected A549 cells.
doi:10.1371/journal.pone.0020804.g008
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the 45 regulators, 17 regulators were downstream targets of
transforming growth factor b-1 (TGFB1), a master switch of EMT
[24], with published evidence (Table S8). This result suggests that
these regulators have crucial roles in TGFB1-induced EMT.
As a control, we tested how well the NetworkProfiler analysis
identified known relationships between regulators and functional
gene sets in the Ingenuity Knowledge Base. The known functional
relationships of the 45 putative master regulators are shown in
Table 2. For example, FOSL1 increases the migration of MDA-
MB-436 cells [25] and the invasion of A549 cells [26]. SMAD3
increases the adhesion [34], the metastasis [35], and the migration
[36] of cells, respectively. Similarly, HIF1A increases the adhesion
of undifferentiated trophoblast stem cells [27], the metastasis of
LM2 cells [41], the migration of HUVEC cells [42], and the
invasion of Achn cells [43], respectively.
Although some of the 47 putative master regulators have not
been reported to enhance the EMT-related functions in IKB,
some predictions were supported by other resent works which
were not included in IKB. For example, the prediction of
NetworkProfiler suggested that PTRF regulates gene sets related
with migration (q-value=2:45|10{8)a n dw i t hm e t a s t a s i s( q-
value=2:03|10{6) during the EMT. Consistent with the in
silico result, PTRF expression inhibits migration and correlates
with metastasis in PC3 prostate cancer cells [61]. Similarly,
NetworkProfiler predicted that miR-146 contributes to migra-
tion (q-value=3:27|10{9)a n di n v a s i o n( q-value=1:01|10{4)
during the EMT. This in silico result is comparable with the in
vitro result that miR-146 inhibits invasion and migration, and
acts as a metastasis suppressor [62]. In addition, some
predictions between miRNAs and functions seem reasonable
based on the known functions of the miRNA host genes. For
example, the prediction of NetworkProfiler provided the
hypothesis that miR-143 and miR-145 promotes metastasis (q-
value=7:17|10{4 and 3:15|10{5)a n dm i g r a t i o n( q-
value=1:37|10{6 and 6:10|10{8), respectively. miR-143
and miR-145 cooperatively target a network of transcription
factors, such as KLF4, to control smooth muscle phenotype
switching [63]. Since KLF4 increases the migration of cells [29]
a n di n d u c e sE M T[ 1 0 ] ,t h e s em i R N A sm i g h tb er e l a t e dw i t h
EMT-related functions or control EMT by targeting KLF4.
Again, it should be noted that these relationships between
regulators and functions cannot be predicted from one gene
network constructed by traditional graphical models, and only
the results of multiple network comparison between epithelial-
like and mesenchymal-like cells based on NetworkProfiler
enables us to support the recent biological knowledge and new
hypotheses about unknown relationships.
Comparison between in silico predictions and in vitro
results
To validate the performance of NetworkProfiler, in silico
predictions obtained by NetworkProfiler were evaluated experi-
mentally. We first conducted in vitro experiments of a new
candidate regulator of E-cadherin listed in Table 1, KLF5, to
investigate whether KLF5 affects E-cadherin expression and
induces morphologic changes characteristic of EMT using A549
lung adenocarcinoma cell line, which is well known to exhibit
EMT in response to TGF-b [64]. KLF5 knockdown markedly
altered a cobblestone epithelial morphology of A549 cells and
induced a more fibroblast-like morphology with reduced cell-cell
contact, which was similar to that seen in TGF-b-treated A549
cells (Figure 7a and Figure S1). Immunofluorescence analysis
showed significant reduction of E-cadherin expression in A549
cells knocked down for KLF5 (Figure 7b), which was also
confirmed by western blot analysis (Figure 7c). Conversely,
vimentin expression was shown to be modestly increased by
siKLF5 treatment (Figure 7c). Consistent with the in vitro results,
the prediction of NetworkProfiler suggested that KLF5 affects E-
cadherin expression as well as Vimentin expression during the
EMT, since the changes in the regulatory effects from KLF5 to E-
cadherin and Vimentin were much larger compared with the
other regulators (12.42 and 16.57, respectively) which was ranked
15-th and 10-th among the 1732 regulators (Table S9). The result
of gene set analysis (Table S7) also suggested that KLF5 affects
EMT (q-value=1:60|10{24). Thus, we consequently found that
in silico predictions obtained by NetworkProfiler was confirmed
with the results of in vitro experiments; KLF5, a newly identified
candidate regulator of EMT, was shown to affect expressions of E-
cadherin and Vimentin as well as morphologic characteristics
related to EMT as a repressor of EMT.
We also conducted in vitro experiments to validate functional
involvement of a novel candidate EMT-related microRNA, miR-
100 whose expression was increased in 762 cancer cell lines during
the EMT (Figure S2). miR-100 was found to be expressed at a low
level in A549, NCI-H727 and NCI-H1439 NSCLC cell lines,
which had low EMT-related modulator values among the 762 cell
lines panel (Figure 8a). miR-100 was transiently introduced into
A549 cells, resulting in a significant increase of cell migration
activity (Figure 8b). However, overexpression of miR-100 did not
affect expressions of an epithelial marker, E-cadherin, and a
mesenchymal marker, vimentin (Figure 8c), and also did not
influence cell morphology (Figure 8d). However, overexpression of
miR-100 significantly increased cell migration without noticeably
affecting morphology in NCI-H727 and NCI-H1437 cells (Figure
S3). Consistent with the in vitro results, the prediction of
NetworkProfiler suggested that miR-100 enhances migration (q-
value=1:42|104) but does not affect EMT itself (q-value=0.24)
from gene set analysis (Table S7). It also suggested that miR-100
does not affect the expressions of E-cadherin and Vimentin during
the EMT, since E-cadherin and Vimentin were not target genes of
miR-100 in all the 762 cell line-specific gene networks related with
the EMT(Files S1, S2, and S3) and the changes in the regulatory
effects from miR-100 to E-cadherin and Vimentin were much
smaller compared with the other regulators (0 and 1.72,
respectively), which were ranked 371-th and 151-th among the
1732 regulators (Table S9). Thus, we conclude that several
hypotheses of miR-100 functions provided by NetworkProfiler are
consistent with the results of in vitro experiments; NetworkProfiler
has the potential to uncover novel biological mechanisms.
Discussion
We developed a novel algorithm called NetworkProfiler to infer
patient-specific, modulator-dependent gene regulatory networks
from gene expression data. Unlike traditional methods that infer a
static network for a specific state of a cell or an averaged network for
many patients, NetworkProfiler can be used to construct patient-
specific gene networks for specific diseases, such as cancer.
Subsequently, information about the regulatory effects of individual
genesandfunctionalgenesetscanbeextractedfromthesenetworks.
In order to show the performance of NetworkProfiler, we applied
NetworkProfiler to microarray gene expression data from 762
cancer cell lines to identify the system changes that were related to
the EMT. As a result, we identified 25 EMT-dependent regulators
of E-cadherin. Although some of these regulators have been
reported in the literature, others may be novel master regulators of
E-cadherin that induce the EMT. Moreover, in comparison to the
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superior for identifying regulators of E-cadherin during the EMT.
We also showed that NetworkProfiler can reveal regulatory changes
of E-cadherin during the EMT. In particular, our results suggested
thatdecreasedexpressionofmiR-141disruptsthenegativefeedback
loop between miR-141 and ZEB1, which would allow ZEB1 to
decrease the expression of E-cadherin.
Furthermore, we also identified putative relationships between
regulators and EMT-dependent functional gene sets, some of
which had published evidence. Based on the significance of the
enrichment of downstream target genes for the regulator on the 5
functional gene sets, we identified 45 putative master regulators for
the EMT. We found that 17 regulators were downstream targets of
TGFB1 that is a master switch of the EMT. We then showed that
NetworkProfiler can not only predict the relationships between
these regulators and functions that were supported by many
published evidence, but also produce new hypotheses that some of
them might enhance EMT-related functions or induce EMT.
Finally, it is of note that we were able to validate the in silico
predictions obtained by NetworkProfiler in our in vitro experiments.
KLF5, a newly identified candidate regulator of EMT, was
experimentally shown to affect E-cadherin expression as well as
morphologic characteristics related to EMT, validating the
NetworkProfiler-based prediction that KLF5 is a negative regulator
of EMT. We also conducted in vitro experiments of another
regulator, miR-100, for which NetworkProfiler predicted its
association with some EMT-associated functions. As a result, we
foundthatthepredictedmiR-100functionsconformedtotheresults
of in vitro experiments. Thus, we conclude that the effectiveness of
the proposed method was validated not only from published
literature but also from new in vitro validation experiments.
We anticipate several possible applications and extensions of
NetworkProfiler. In this study, we only focused on the system
changes that are associated with the EMT. NetworkProfiler also
could be used to infer system changes and reconstruct modulator-
dependent gene networks for other well-defined modulators, such
as drug sensitivity and prognosis risk. Currently, a significant
limitation of NetworkProfiler is that the modulator must be one-
dimensional. However, cancer development is a multivariate
process. It may be possible to use multivariate kernel functions in
NetworkProfiler to overcome this limitation.
During the past decade, cancer therapy has become increasingly
personalized [2,3]. Unlike the traditional ‘‘one-size-fits-all’’
approach to cancer therapy, patient-specific cancer therapy
reduces the side effects of chemotherapy and predicts the odds
of cancer recurrence more accurately by tailoring cancer
treatment to specific genetic defects in the tumors of individual
patients. However, this goal is not an easy task since cancer is an
extremely complex and heterogeneous disease. We believe that
NetworkProfiler will help elucidate the systems biology of cancer
and facilitate personalized chemotherapy.
Materials and Methods
Cell lines and reagents
Humannon-smallcelllungcancer(NSCLC)celllines,A549,NCI-
H1437 and NCI-H727, were purchased from American Tissue
Culture Collection, while other NSCLC cell lines, Calu1, Calu6 and
SK-MES1, were generously provided by Dr. L. J. Old (Memorial
Sloan-Kettering Cancer Center). Cells were maintained in RPMI
1640 supplemented with 10% fetal bovine serum. The anti-E-
cadherin antibody was purchased from BD Transduction Labora-
tories, anti-vimentin from Santa Cruz Biotechnology, anti-a-tublin
from Sigma Aldrich, and anti-mouse IgG from Cell Signaling
Technology. The Alexa-conjugated anti-mouse IgG was purchased
from Molecular Probes. siRNAs against KLF5 (siKLF5 #1a n d#2)
and a negative control (siNC) were purchased from Sigma Genosys.
Pre-miR has-miR-100 and negative control #2 were purchased from
Ambion. Human TGF-b was purchased from R&D Systems, Inc.
Immunostaining, western blot analysis and in vitro
motility assay
2|104 cellsin6-wellplatesweretransientlytransfectedwitheither
20 nM siRNA or 10 nM Pre-miR molecules using Lipofectamine
RNAiMAX (Invitrogen), as previously described [65]. Immunoflu-
orescence staining was carried out after fixation with 3.7%
formaldehyde and postfixing with 0.1% Triton X-100 each for
10 min at RT. Photographs were taken 72 hr after transfection. Cells
were harvested 48 hr after transfection for western blot analysis. In
vitro motility assay based on Transwell-chamber culture systems was
performed, as previously described [66].
Quantitative real-time reverse transcription (RT)-PCR
analysis
Quantitative real-time RT-PCR analysis of KLF5 was per-
formed using Power SYBR Green (Applied Biosystems) and the
following PCR primers:
59-CCCTTGCACATACACAATGC-39 and 59-GGATGGA-
GGTGGGGTTAAAT-39. Quantitative real-time RT-PCR anal-
ysis of miR-100 and RNU44 was performed using TaqMan
probes and 7500 Fast Real-Time PCR system (Applied Biosys-
tems), essentially as previously described [67].
NetworkProfiler
NetworkProfiler employed a varying-coefficient structural
equation model (SEM) to represent the modulator-dependent
conditional independence between gene transcripts. Let there be q
possible regulators, R1,...,Rq, that may control the transcription
of the k-th target gene Tk when the modulator M~m. Then the
varying-coefficient structural equation model for Tk is
Tk~
X q
j~0
bjk(m):Rjzek,
where bjk(m) is the coefficient function that represents the effect of
Rj on Tk, R0~1, and ek is a noise term. If Tk~Rl, then the term
blk(m):Rl can be omitted from the model, i.e., blk(m)~0 for all m.
By estimating the parameters bjk(m), we obtain the transcriptional
regulatory gene network at M~m.
We used a kernel-based method to estimate these parameters.
Let there be n sets of gene expression profiles. Then, the SEM for
the a-th sample can be rewritten as
tak~
X q
j~0
bjka:rajzeak,a~1,...,n,
where tak, raj, and ma are the values of the k-th target gene, the j-
th regulator, and the modulator for the a-th sample, respectively;
r0k~1, and bjka~bjk(ma). For n samples, we obtain n modulator-
dependent gene regulatory networks, i.e., the regulatory effects of
Rj (j~1,...,q)o nTk (k~1,...,p) are determined by
^ b b111,...,^ b bqpn, where ^ b bjka is the estimate of bjka.
We assumed that the values of the coefficients are almost
constant for the neighborhood samples of the a-th sample with
respect to the modulator m, that is, bjki&c for the i-th sample that
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estimated the parameters bjka for fixed a by minimizing a
regularized kernel-based weighted residual sum of squares
Lk(b1ka,...,bqkajhk)~
1
2
X n
i~1
ftik{
X q
j~1
bjka:rijg
2K(mi{majhk)
zlka
X q
j~1
wjka: bjka
       z
cka
2
X q
j~1
b
2
jka, ð1Þ
where K(mi{majhk) is a Gaussian kernel function defined by
K(mi{majhk)~exp {
1
hk
(mi{ma)
2
  
,
and lka and cka are hyperparameters that control the L1 (lasso
[68]) and L2 (ridge [69]) penalties, respectively. In addition, wjka is
an importance weight for bjka, and hk is the bandwidth of the
Gaussian kernel. The kernel function K(mi{majhk) defines the
neighborhood around the a-th sample in terms of M; a large value
of K(mi{majhk) means that the i-th sample is in the
neighborhood of the a-th sample. By fixing lka, cka, wjka, and
hk, we obtain the estimates
f^ b b1ka,...,^ b bqkag~argmin
bjka
Lk(b1ka,...,bqka):
This parameter estimation method is a weighted version of the
elastic net [22]. The L1 penalty zeroes some coefficients [68],
which produces a sparse network structure. In contrast, the L2
penalty stabilizes the solution by a grouping effect that promotes
the collective inclusion or exclusion of highly correlated variables
in the model [22]. The importance weights wjka allow tuning
parameters to take on different values for different coefficients bjka.
For example, if wjka has a large value, then an estimator ^ b bjka tends
to be zero. In contrast, if wjka has a small value that is nearly equal
to zero, ^ b bjka tends to be non-zero. These weights create a sparser
network structure than the lasso and elastic net methods. The
parameters bjka were estimated by using a recursive procedure,
and the weights wjka were updated by wjka~1=(~ b bjkazj) [70],
where ~ b bjka is the estimate from the previous step and j~10{5 to
avoid dividing by zero. Then, the modulator-dependent networks
for n samples can be derived from the estimates of ^ b bjka
(j~1,...,q, k~1,...,p, and a~1,...,n).
For convenience of subsequent explanations, we introduce the
following notations:
tka(hk)~
k1a(hk):t1k
. .
.
kna(hk):tnk
0
B B B @
1
C C C A
,and
Ra(hk)~
k1a(hk):r11     k1a(hk):r1q
. .
.
P . .
.
kna(hk):rn1     kna(hk):rnq
0
B B B @
1
C C C A
,
where kia(hk)~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K(mi{majhk)
p
.
In these expressions, tka(hk) and Ra(hk) were normalized so that
the means and variances for tka(hk) and each column of Ra(hk)
were 0 and 1, respectively. As a result, the intercept b0ka was not
included in the loss function (1). For fixed hk, the loss function (1)
can be minimized by using a kernel-based weighted version of the
recursive elastic net [70]. The tuning parameters lka and cka were
selected by minimizing a modified version of the bias-corrected
weighted Akaike information criterion (AIC) [71]:
mWAICcka~(na(hk)z1):log(2p^ s s2
ka)z
2na(hk)(^ d df kaz1)
na(hk){^ d df ka{2
,
where na(hk)~
Pn
i~1 kia(hk), and ^ s s2
ka is estimated by
^ s s2
ka~
1
na(hk)
Etka(hk){Ra(hk)^ b bkaE
2
2,
with ^ b bka~(^ b b1ka,...,^ b bqka)’. In addition, ^ d dfka is the unbiased
estimate of the degrees of freedom given by
^ d dfka~tr (~ R R(hk)’~ R R(hk)zckaI)
{1~ R R(hk)’~ R R(hk)
  
,
where I is the identify matrix and ~ R R(hk) is the submatrix of R(hk),
which has columns that correspond to the nonzero coefficients,
respectively.
The NetworkProfiler algorithm is shown below:
Algorithm: NetworkProfiler.
1: ~ w wjka / 1( j~1,...,q)
2: iter / 1
3: for cka~c½r  (r~1,...,G) do
4: repeat
5: Calculate ^ b bka½l,r  and mWAICcka½l,r  corresponding to
lka~lk½l  (l~1,...,L).
6: zr½iter  / minfmWAICcka(l,r);l~1,...,Lg
7: l /arg minlfmWAICcka(l,r);l~1,...,Lg
8: if zr½iter {zr½iter{1 w0 then
9: Exit loop
10: else
11: z ½r /zr½iter 
12: ~ b bka½r  / ^ b bka½l ,r 
13: ~ w wjka/1=(j~ b bjka(r)jzj) (j~1,...,q)
14: iter/iterz1
15: end if
16: untill iter reaches to M.
17: end for
18: r /arg minrfz ½r ;r~1,...,Gg
19: Return the coefficient vector ^ b bka~~ b bka½r  .
The results from NetworkProfiler, which are the estimates of q
coefficients ^ b bjka (j~1,...,q) for the k-th target gene of the a-th
patient, depend on the values of hk. We used cross-validation to
select an optimal value of hk and estimate q|n coefficients,
b1k1,...,bqkn by minimizing the cross-validation error:
CVk~
X
a[S
(tak{
X q
j~0
^ b b
({a)
jka :raj)
2, ð2Þ
where S is a randomly selected set of samples and ^ b b
({a)
1ka ,...,^ b b
({a)
qka
are estimated from the remaining samples by minimizing:
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k (b1ka,...,bqkajhk)~
1
2
X
i = [S
ftik{
X q
j~0
bjka:rijg
2K(mi{majhk)
zlka
X q
j~1
wjka:jbjkajz
cka
2
X q
j~1
b
2
jka: ð3Þ
The algorithm in NetworkProfiler for minimizing this loss
function (3) is shown below:
Algorithm: Conditional optimization with cross-
validation.
1: for hk~hl (l~1,...,H) do
2: for all a such that a[S do
3: Calculate ^ b b
({a)
1ka ½hl ,...,^ b b
({a)
qka ½hl  with NetworkProfiler.
4: end for
5: Calculate CVk½hl .
6: end for
7: h 
k/argminhlfCVk½hl ;l~1,...,Hg
8: for a~1,...,n do
9: Calculate ^ b b1ka½h 
k ,...,^ b bqka½h 
k  with NetworkProfiler.
10: end for
11: Return a sequence of the coefficient vectors
^ b bk1(h 
k),...,^ b bkn(h 
k).
Subsequently, the modulator-dependent gene networks for n
samples are determined from the coefficient vectors ^ b bk1(^ h hk), ...,
^ b bkn(^ h hk) (k~1,...,p) by applying the above algorithm for all
k~1,...,p. The computational cost of this algorithm rapidly
increases as the number of samples and genes increase. Thus, for
computers that onlyhave a single centralprocessing unit (CPU), this
algorithm is only practical for medium-sized networks with up to
several genes. However, since this algorithm can be executed in
parallel for every k, it can be run on a stand-alone workstation with
multi-core CPUs and computer clusters. Figure S4 represents the
histogram of computational times based on 12 core CPUs (Intel
Xeon Processor E5450 (# of cores=4, clock speed=3.0GHz) | 3)
for calculating 762 cancer cell line-specific gene networks from
13,508 | 762 gene expression data through 100,000 iterations
when 100 target genes were randomly selected among 13,508 genes
andthe numberofregulatorswasnotrestricted,i.e.,1732regulators
were used. The average computational time was about 9 days. In
this situation, we can find putative master regulators of the focused
target genes related with a modulator of interest. Of course, for
calculating gene networks of 762 samples for a large number of
target genes, a supercomputer is required. In this study, we used the
Super Computer System at the Human Genome Center, Institute
ofMedicalScience,UniversityofTokyo,Japan,toanalyze762 gene
networks with 13,508 target genes.
Signature-based hidden modulator extraction
When the modulator was a variable that is difficult to observe,
we used a signature-based hidden modulator extraction algorithm
to estimate the value of the modulator for each sample. This
algorithm takes seed genes that are related to the modulator and
computes the underlying latent variable of the modulator by using
principal components and extraction of expression modules (EEM)
[7]. Let M be a gene set that is related to the modulator and let
XM be an n|jMj matrix of n expression levels of M. Then, a
linear model, which is a special case of the single factor model
[72], relates M
 , a subset of M, to an underlying latent variable U
as follows:
Xj~a0jza1jUze’j, j[M
 (M, ð4Þ
where Xj is the expression level of the j-th gene in M
 , a0j is the y-
intercept, a1j is a coefficient, and e’j is a noise term. We assumed
that other genes that do not include M
  (fXj;j 6[M
 g) are
independent of U.
The values of U for n samples, ui (i~1,...,n), can be estimated
by the following procedure:
Algorithm: signature-based hidden modulator
extraction.
1: For a given set M, find a subset M
  based on the expression
coherence with the EEM algorithm [7].
2: Given M
 , singular value decomposition of the data matrix
XM
  estimates ui by the largest principal component.
3: Return the values ui (i~1,...,n).
In the first step, we estimate M
 . In the second step, we assume
that the noise terms e’j have Gaussian distributions with equal
variances. As a result, the singular value decomposition generates
maximum likelihood estimates of ui for the single factor model
[72].
Regulatory effect
To identify upstream regulators that had strong effects on the
expression of a target gene of interest in the constructed
modulator-dependent gene networks, we defined a measure,
called the regulatory effect, of the effect of the j-th regulator on
the k-th target gene in the a-th sample as
REjka~
X
l[pjka
^ b b
(j?k)
l (ma):raj, ð5Þ
where pjka is the set of all possible paths from Rj to Tk, and
^ b b
(j?k)
l (ma) is the product of the estimated coefficients on the l-th
path that includes pjka. For example, given all the possible paths
from R1 to T2 in the a-th sample (Figure S5), the set p12a is
p12a~fR1?T2,R1?R3?T2,R1?R3?R4?T2g, ð6Þ
and the regulatory effect RE12a is
RE12a~(^ b b12az^ b b13a:^ b b32az^ b b13a:^ b b34a:^ b b42a):raj: ð7Þ
In our analysis, the length of the paths from Rj to Tk is restricted
to either 1 or 2.
To determine how the modulator affects the regulatory effect
REjka, we also defined the change in the regulatory effect of the j-
th regulator on the k-th target as
RECjk~maxfREjka;a~1,...,ng{minfREjka;a~ 1,...,ng: ð8Þ
In addition to this definition, it is also possible to use percentiles
instead of max and min to achieve more robust results. However,
in our analysis, we used max and min to increase the power of the
method. It should be noted that the change in the regulatory effect
RECjk does not explain the mode of action for the modulator with
respect to the regulator-target relationship. File S5 (http://
bonsai.hgc.jp/,shima/NetworkProfiler) is provided to determine
the modulator mode of action by statistical test.
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To identify regulators that enhanced the functions of their
targets, we calculated the statistical significance of the enrichment
of targets for a given regulator in each sample. To test the
enrichment, we use the degree of independence between the two
properties:
Aja :gene is in the list of targets for the j-th regulator in the
a{th sample
Bu :gene is a member of the u-th priori set
Testing the association between the properties Aja and Bu
corresponds to Fisher’s exact test. The p-value calculated by this
test, Pjua, indicates the probability of observing at least the same
amount of enrichment when downstream genes are randomly
selected out of all genes. Thus, a very small p-value gives strong
evidence for an association between Aja and Bu for the j-th
regulator in the a-th sample. To correct for multiple hypotheses
testing, Benjamini-Hochberg (BH)-corrected p-values (q-values)
[73], Qjua, were calculated.
To determine how the modulator affects the functions of
downstream genes for a regulator, we defined the enrichment
score, ESju, as a change in the statistical significance of the
enrichment of targets for the j-th regulator on the u-th function:
ESju~log(maxfQjua;a~1,...,ng=minfQjua;a~1,...,ng): ð9Þ
Thus, a very large ESju indicates that the modulator causes a
significant change of the enrichment of the targets for the j-th
regulator on the u-th function.
To identify putative master regulators that control more
functional gene sets than other regulators, we also calculated the
total enrichment score, TESj, by combining independent
enrichment scores, ESj1,...,ESjU, where U is the number of
functional gene sets:
TESj~2
X U
u~1
ESju: ð10Þ
The total enrichment score is equivalent to the difference of the
Fisher’s statistic {2
Pk
i~1 log Pk [74] which was used to combine
independent tests obtained from k studies based on the p-values,
P1,...,Pk. The Fisher’s method is based on the fact that the
statistic {2
Pk
i~1 log Pi follows a chi-square distribution with 2k
degrees of freedom under the global null hypothesis that all null
hypotheses are true. A small integral p-value for the hypothesis
indicates that the j-th regulator controlled at least one or more
functional gene sets during the change of the modulator.
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Figure S1 Quantitative real-time RT-PCR analysis of
KLF5 in siKLF5-treated A549 cells.
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Figure S2 Expression profiles of miR-100 in order of
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Figure S3 miR-100-induced changes in biologic charac-
teristics in NCI-H1437 and NCI-H727 NSCLC cell lines.
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negligible changes in morphology by miR-100 introduction in
both NSCLC cells lines. NC#2, negative control. (b) Motility
assay showing increased migration by introduction of miR-100 in
both NSCLC cell lines. *, Pv0:05:
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Figure S4 Histogram of computational times for infer-
ring cancer cell line-specific gene networks running on
12 core CPUs. The 762 cancer cell line-specific gene networks
related with the EMT were calculated from 13,508 | 762 gene
expression data when 100 target genes were randomly selected
among 13,508 genes and the number of regulators was not
restricted, i.e., 1,732 regulators were used. The comptational times
were based on 12 core CPUs (Intel Xeon Processor E5450 (# of
cores =4, clock speed =3.0 GHz)|3). The histogram was
calculated by 100,000 iterations.
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Figure S5 Example of paths among four genes, R1, T2,
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Table S1 List of candidate regulators mapped to 1183
transcription factors and 47 nuclear receptors.
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Table S2 List of candidate regulators mapped to 502
human microRNAs.
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Table S3 List of coherent genes (p-valuev10{5) related
to EMT calculated by extraction of expression module
(EEM).
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Table S4 EMT-related modulator values of 762 cancer
cell lines calculated by signature-based hidden modula-
tor extraction.
(XLS)
Table S5 List of 370 putative master regulators of E-
cadherin during the EMT which were estimated by
NetworkProfiler.
(XLS)
Table S6 List of 627 putative master regulators of E-
cadherin which were estimated by a structual equation
model (SEM) with the elastic net.
(XLS)
Table S7 Regulator function matrix between 1732
regulators and 5 functions. The row and column indicate
regulator and functional gene set, respectively. The (i,j)-th element
represents the change during the EMT in the statistical
significance (-log10(q-value)) for the enrichment of target genes
of the i-th regulator on the j-th function. The last column indicate
the integral q-value of each row regulator which were used to
determine which regulator strongly affected the functional gene
sets.
(XLS)
Table S8 List of 17 putative master regulators (integral
q-valuev10{10) which correlated at least one or more
EMT-related functions and were known to be down-
stream targets of TGFB1 with published evidence from
Ingenuity Knowledge Base (http://www.ingenuity.com).
(XLS)
Table S9 List of the changes in the regulatory effects
from 1732 regulators to E-cadherin and vimentin during
the EMT.
(XLS)
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